| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 07/27/2005 | EP1556020A2 Use of cgrp antagonist compounds for treatment of psoriasis |
| 07/27/2005 | EP1556008A1 Use of bases for the manufacture of a medicament in the treatment of different forms of inflammatory dermatosis |
| 07/27/2005 | EP1555999A2 Cosmetic or dermopharmaceutical compositions containing kombucha |
| 07/27/2005 | EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists |
| 07/27/2005 | EP1289559B1 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/27/2005 | EP1283823A4 Novel mmp-2/mmp-9 inhibitors |
| 07/27/2005 | EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors |
| 07/27/2005 | EP1263757B1 Benzthiazoles as tnf and pde-iv inhibitors |
| 07/27/2005 | EP1237877B1 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 07/27/2005 | EP1185527B1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds |
| 07/27/2005 | EP1067896B1 Topical compositions comprising ascorbyl-phosphoryl-cholesterol |
| 07/27/2005 | EP0990000B1 Connective tissue growth factor-3 |
| 07/27/2005 | EP0986561B1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/27/2005 | EP0799051B1 Irrigation solution and use thereof for perioperatively inhibiting pain, inflammation and spasm at a wound |
| 07/27/2005 | CN2712931Y Electromagnetic cleavage device for cleavage extracting polypeptide from vegetable protein |
| 07/27/2005 | CN1646627A Solid emulsions based on thermoplastic elastomers |
| 07/27/2005 | CN1646558A Histone deacetylase inhibitors and process for producing the same |
| 07/27/2005 | CN1646537A Phosphorus-containing compounds & uses thereof |
| 07/27/2005 | CN1646535A Pyrrolopyrimidine derivative |
| 07/27/2005 | CN1646533A 1-[alkyl], 1-[heteroaryl]alkyl] and 1-[aryl]alkyl]-7-(pyrimidin-4-yl)-imadazo[1, 2-a]pyrimidin-5(1H)-one derivatives |
| 07/27/2005 | CN1646531A Thioxanthine derivatives as myeloperoxidase inhibitors |
| 07/27/2005 | CN1646526A Tropane derivatives as CCR5 modulators |
| 07/27/2005 | CN1646520A 1, 3, 5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 07/27/2005 | CN1646509A Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 07/27/2005 | CN1646507A Aminophenylbenzothiazole compounds |
| 07/27/2005 | CN1646505A Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/27/2005 | CN1646504A Substituted benzoxazoles and analogues as estrogenic agents |
| 07/27/2005 | CN1646502A Triazole derivatives as tachykinin receptor antagonists |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/27/2005 | CN1646480A Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 07/27/2005 | CN1646473A Novel curcumin analogues and uses thereof |
| 07/27/2005 | CN1646160A Anti-alpha V beta 6 antibodies |
| 07/27/2005 | CN1646154A Albumin-fused anti-angiogenesis peptides |
| 07/27/2005 | CN1646151A Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis |
| 07/27/2005 | CN1646143A Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 07/27/2005 | CN1646138A Novel therapeutical use of agonist ligands specific to G2A receptor |
| 07/27/2005 | CN1646133A Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 07/27/2005 | CN1646131A Novel compounds |
| 07/27/2005 | CN1646124A Use of materials having zinc ionophoric behavior |
| 07/27/2005 | CN1646121A Methods for modulating phototoxicity |
| 07/27/2005 | CN1646114A Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
| 07/27/2005 | CN1646101A Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations |
| 07/27/2005 | CN1646100A Dispersed solid-containing complex carbohydrate |
| 07/27/2005 | CN1646093A Method and composition for treatment of inflammation and AIDS-associated neurological disorders |
| 07/27/2005 | CN1646092A Soy composition for balancing combination skin |
| 07/27/2005 | CN1646090A New composition including a pigment assembly comprising a mica core |
| 07/27/2005 | CN1646080A Compositions and methods for inducing new hair follicle formation and hair growth in a desired orientation |
| 07/27/2005 | CN1646078A Composition for cell proliferation |
| 07/27/2005 | CN1644207A Chinese medicinal preparation for treating skin disease |
| 07/27/2005 | CN1644206A Medicine for treating tinea containing biological alkaline salt and preparation thereof |
| 07/27/2005 | CN1644204A Dermitis tincture |
| 07/27/2005 | CN1212166C Safety shield system for prefilled syringes |
| 07/27/2005 | CN1212137C Hair follice activating liquid |
| 07/27/2005 | CN1212133C Beautifying health composition and its preparation |
| 07/27/2005 | CN1212130C Medicine for treating psoriasis, ichthyosis and eczema |
| 07/27/2005 | CN1212120C Ointment prescription for treating trauma |
| 07/27/2005 | CN1212111C Chinese medicinal skin-beautiful honey and preparing method thereof |
| 07/26/2005 | US6921826 Thioether substituted imidazoquinolines |
| 07/26/2005 | US6921777 E.g., ethyl 3-methyl-5-(,5,8,8-tetra-methyl-5,6,7,8-tetra-hydronaphthalen-2 -ylselenyl)pent-2-en-4-ynoate; dermatological, rheumatic, respiratory, cardiovascular and ophthalmological uses as well as cosmetic uses |
| 07/26/2005 | US6921763 Protein kinase inhibitors |
| 07/26/2005 | US6921762 Substituted indolizine-like compounds and methods of use |
| 07/26/2005 | US6921540 Hypotonic brines comprising mixtures of sodium, potassium, magnesium, calcium, chlorine and sulfates in water, used for prevention of inflammation of mucous membranes and for dissolving plugs in ears |
| 07/26/2005 | CA2315481C Selective inhibition of aggrecanase in osteoarthritis treatment |
| 07/26/2005 | CA2269115C Monovalent antibody fragments |
| 07/21/2005 | WO2005065700A1 Life-prolonging agent comprising polished rice-origin components as the active ingredient |
| 07/21/2005 | WO2005065670A1 Use of idebenone for the preparation of a topically-applied depigmentation composition and corresponding composition |
| 07/21/2005 | US20050160483 Glycosaminoglycan deficient proteoglycan expressed in recombinant goat; antiscarring agents and reconstructive/cosmetic surgery |
| 07/21/2005 | US20050159695 Comprises antimicrobial substances, pain relievers, protease inhibitors, kallikrein, and tissue-plasminogen activator |
| 07/21/2005 | US20050159611 Process for producing shogaols and intermediates for the synthesis thereof |
| 07/21/2005 | US20050159589 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 07/21/2005 | US20050159474 Chemical compounds |
| 07/21/2005 | US20050159467 5-Aryltetrazole compounds and uses thereof |
| 07/21/2005 | US20050159456 Method of treating of demyelinating diseases or conditions |
| 07/21/2005 | US20050159443 For example, N-[2,4-dichloro-3-(2-methyl-quinolin-8-yloxymethyl)-phenyl]-N-methyl-2-[1-methyl-5-(3-methyl-4-nitro-benzoyl)-1H-pyrrol-2-yl]-acetamide; bradykinin receptor agonists; for treating disorders such as pain, inflammation, asthma and allergy |
| 07/21/2005 | US20050159434 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents |
| 07/21/2005 | US20050159418 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/21/2005 | US20050159407 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 07/21/2005 | US20050159397 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent |
| 07/21/2005 | US20050159395 Topical applying to skins; skin disorders; anticarcinogenic agents |
| 07/21/2005 | US20050159359 Methods and compositions for derepression of IAP-inhibited caspase |
| 07/21/2005 | US20050159338 Administering factor XIII systemically or locally optionally in conjunction with activated thrombin. |
| 07/21/2005 | US20050159335 Pharmaceutical administration form for peptides, process for its preparation, and use |
| 07/21/2005 | US20050158828 Preparing immunoglobulin dimer for use in prevention and treatment of B cell lymphoma and chronic lymphocytic leukemia; immunotherapeutics |
| 07/21/2005 | US20050158407 Antipyrotic and method of manufacturing the same |
| 07/21/2005 | US20050158404 Composition and method for treatment of acne |
| 07/21/2005 | US20050158358 Tissue engineering scaffolds promoting matrix protein production |
| 07/21/2005 | US20050158357 Polymer tether covalently coupled to the scaffold; and a matrix-enhancing molecule that is covalently coupled to the polymer tether, such as ascorbic acid, angiotensin II, and/or insulin-like growth factor, to elicit production of extracellular matrix by a cell attached to the scaffold |
| 07/21/2005 | US20050158350 Use of licochalcone a or of an extract of radix glycyrrhizae inflatae that contains licochalcone a against postinflammatory hyperpigmentation |
| 07/21/2005 | US20050158291 Pet food composition for skin photoprotection |
| 07/21/2005 | US20050158288 Methods of organ regeneration |
| 07/21/2005 | US20050158263 Pyrithione biocides enhanced by zinc metal ions and organic amines |
| 07/21/2005 | DE10356187A1 Wirkstoffkombinationen aus Phytosterolen und/oder Cholesterin und Licochalcon A oder einem wäßrigen Extrakt aus Radix Glycyrrhizae inflatae, enthaltend Licochalcon A Active compound combinations of phytosterols and / or cholesterol and licochalcone A or an aqueous extract of Radix Glycyrrhizae inflatae containing licochalcone A |
| 07/21/2005 | CA2552483A1 Use of idebenone for the preparation of a topically-applied depigmentation composition and corresponding composition |
| 07/21/2005 | CA2552090A1 Disubstituted chalcone oximes as selective agonists of rar.gamma. retinoid receptors |
| 07/21/2005 | CA2551862A1 Piperazines useful for treating pain |
| 07/21/2005 | CA2551525A1 Pharmaceutical composition for thrombin peptide derivatives |
| 07/20/2005 | EP1555031A1 Angiogenesis inducer |
| 07/20/2005 | EP1555028A1 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |